How Do We Differentiate Science from Science Fiction? | Interview

Mike Totterman is a successful entrepreneur in medical devices, pharmaceutical clinical trials and commercialization of academic inventions in several fields of medicine. He explains the process of due diligence as it is applied by early stage investors to the evaluation of new technologies in medicine, understanding the risks, evaluation of scalability and reliability in manufacturing. We look at Moderna investor presentation from 2018 as an example of lack of disclosure or due diligence.